HCG 5000IU Injection contains Human Chorionic Gonadotropin (hCG) at a concentration of 5000 International Units per vial. It is a glycoprotein hormone produced during pregnancy by the placental trophoblast cells and is used therapeutically for its luteinizing hormone (LH)-like activity. This injection is primarily indicated for the treatment of hypogonadism in males, including conditions such as cryptorchidism and delayed puberty, by stimulating testosterone production and spermatogenesis. In females, it is used to induce ovulation and support luteal function in assisted reproductive technologies such as in vitro fertilization (IVF). HCG 5000IU Injection is administered intramuscularly or subcutaneously, with dosage and duration tailored according to the specific clinical indication and patient response. The medication should be reconstituted with sterile water prior to administration. Common adverse effects may include injection site reactions, headache, irritability, and mild gynecomastia in males. Caution is advised in patients with hormone-sensitive tumors or hypersensitivity to hCG or any excipients. Proper medical supervision is essential to monitor therapeutic efficacy and minimize potential risks. This product should be stored as per manufacturer guidelines to maintain stability and potency.